January 9, 2006

By U.S. Mail and facsimile to (310) 205-9909

Mr. Joseph Spellman
Chief Executive Officer
Davi Skin, Inc.
301 North Canon Drive, Suite #207
Beverly Hills, CA  90210

	RE:  	Davi Skin, Inc.
		Form 8-K Item 4.01
		Filed January 9, 2006
		File # 001-14297

Dear Mr. Spellman:

      We have reviewed your filing and have the following
comments.
If you disagree, we will consider your explanation as to why our
comments are inapplicable.  Please be as detailed as necessary in
your explanation.  In some of our comments, we may ask you to
provide
us with supplemental information so we may better understand your
disclosure.  After reviewing this information, we may or may not
raise additional comments.

      Please understand that the purpose of our review process is
to
assist you in your compliance with the applicable disclosure
requirements and to enhance the overall disclosure in your filing.
We look forward to working with you in these respects.  We welcome
any questions you may have about our comments or on any other
aspect
of our review.  Feel free to call us at the telephone number
listed
at the end of this letter.

1. Item 304(a)(1)(ii) of Regulation S-B requires a statement
whether
the accountant`s reports on the financial statements for either of
the past two years contained an adverse opinion or a disclaimer of
opinion or was qualified or modified as to uncertainty, audit
scope
or accounting principles; and a description of the nature of each
such adverse opinion, disclaimer of opinion, modification or
qualification.  Please revise your filing accordingly.  We note
the
disclosure in your Exhibit 16 that your former accountants
reported
on the years ended December 31, 2004 and 2003.

2. We note your disclosure that there were no disagreements with
your
former accountant from inception through the interim period ended
January 1, 2006.  Revise your filing to disclose, if true, that
there
were no disagreements with your former accountant during the two
most
recent fiscal years (disclose specific years) and through the
actual
date of change (interim period).  In addition, revise your
disclosure, if true, that the former accountants did not advise
the
Company with any of the matters described in paragraphs
(a)(1)(iv)(B)
of Item 304 over a similar period.  Refer to Item 304 (a)(1) of
Regulation S-B.

3. To the extent that you make changes to the Form 8-K to comply
with
our comments, please obtain and file an updated Exhibit 16 letter
from the former accountants stating whether the accountant agrees
with the statements made in your revised Form 8-K.


*  *  *  *  *

	We urge all persons who are responsible for the accuracy and
adequacy of the disclosure in the filing reviewed by the staff to
be
certain that they have provided all information investors require.
Since the company and its management are in possession of all
facts
relating to a company`s disclosure, they are responsible for the
accuracy and adequacy of the disclosures they have made.

      In connection with responding to our comments, please
provide,
in writing, a statement from the company acknowledging that

* the company is responsible for the adequacy and accuracy of the
disclosure in the filing;
* staff comments or changes to disclosure in response to staff
comments in the filing reviewed by the staff do not foreclose the
Commission from taking any action with respect to the filing; and
* the company may not assert staff comments as a defense in any
proceeding initiated by the Commission or any person under the
federal securities laws of the United States.

      In addition, please be advised that the Division of
Enforcement
has access to all information you provide to the staff of the
Division of Corporation Finance in our review of your filing or in
response to our comments on your filing.

      Please file your supplemental response via EDGAR in response
to
these comments within 5 business days of the date of this letter.
Please note that if you require longer than 5 business days to
respond, you should contact the staff immediately to request
additional time.  You may wish to provide us with marked copies of
each amended filing to expedite our review.  Direct any questions
regarding the above to the undersigned at (202) 551-3739.

								Sincerely,



								Ryan Rohn
								Staff Accountant
??

??

??

??

Mr. Joseph Spellman
Davi Skin, Inc.
January 9, 2006
Page 1



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549-7010

         DIVISION OF
CORPORATION FINANCE